Simulating Viral Dynamics in the New Trial Simulator

Antiviral drug development presents a unique set of challenges. First, viruses are constantly mutating, and drug-resistant viruses emerge easily. Therefore, combination therapies are typically required to maintain a sustained virologic response. In addition, successful treatment requires high medication adherence, which is often a challenge for patients with chronic viral infections such as hepatitis or HIV. … Continued

1 of 1
Back to top
Powered by GlobalLink OneLink Software